AbCellera Biologics Inc.
General ticker "ABCL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.0B (TTM average)
AbCellera Biologics Inc. follows the US Stock Market performance with the rate: 48.3%.
Estimated limits based on current volatility of 2.3%: low 3.45$, high 3.61$
Factors to consider:
- Total employees count: 600 (+2.4%) as of 2024
- US accounted for 9.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Fluctuating operating results, Economic downturns and volatility, Regulatory and compliance, Supply chain disruptions, Market competition
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.66$, 6.15$]
- 2026-12-31 to 2027-12-31 estimated range: [2.46$, 5.78$]
Financial Metrics affecting the ABCL estimates:
- Positive: with PPE of -7.2 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.37 <= 0.01
- Positive: Investing cash flow per share per price, % of 8.27 > -0.63
- Positive: Shareholder equity ratio, % of 74.80 > 64.29
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term ABCL quotes
Long-term ABCL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $38.02MM | $28.83MM | $75.13MM |
| Operating Expenses | $275.23MM | $343.60MM | $292.23MM |
| Operating Income | $-237.21MM | $-314.77MM | $-217.10MM |
| Non-Operating Income | $63.18MM | $114.37MM | $39.51MM |
| R&D Expense | $175.66MM | $167.26MM | $186.83MM |
| Income(Loss) | $-174.03MM | $-200.40MM | $-177.59MM |
| Taxes | $-27.63MM | $-37.54MM | $-31.18MM |
| Profit(Loss)* | $-146.40MM | $-162.86MM | $-146.41MM |
| Stockholders Equity | $1,152.32MM | $1,056.08MM | $1,141.36MM |
| Inventory | $1.11MM | $0.00MM | $6.34MM |
| Assets | $1,488.09MM | $1,360.55MM | $1,356.95MM |
| Operating Cash Flow | $-43.88MM | $-108.56MM | $-131.29MM |
| Capital expenditure | $77.51MM | $78.40MM | $42.77MM |
| Investing Cash Flow | $-221.11MM | $121.41MM | $87.75MM |
| Financing Cash Flow | $10.36MM | $12.77MM | $14.08MM |
| Earnings Per Share** | $-0.51 | $-0.55 | $-0.49 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.